• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Critical care for severe coronavirus disease 2019: a population-based study from a province with low case-fatality rate in China.

作者信息

Liao Xue-Lian, Chen Hong, Li Zhen, Wang Bo, Zhang Zhong-Wei, Li Wei-Min, Liang Zong-An, Tang Jin, Wang Jian, Shi Rui, Jin Xiao-Dong, Kang Yan

机构信息

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

Department of Critical Care Medicine, Public Health Clinical Centre of Chengdu, Chengdu, Sichuan 610066, China.

出版信息

Chin Med J (Engl). 2020 Nov 3;134(1):98-100. doi: 10.1097/CM9.0000000000001187.

DOI:10.1097/CM9.0000000000001187
PMID:33395074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7862801/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9714/7862801/14c6e2b95445/cm9-134-098-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9714/7862801/14c6e2b95445/cm9-134-098-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9714/7862801/14c6e2b95445/cm9-134-098-g001.jpg

相似文献

1
Critical care for severe coronavirus disease 2019: a population-based study from a province with low case-fatality rate in China.2019年新型冠状病毒重症病例的重症监护：来自中国一个低病死率省份的基于人群的研究
Chin Med J (Engl). 2020 Nov 3;134(1):98-100. doi: 10.1097/CM9.0000000000001187.
2
Age-stratified analysis of SARS-CoV-2 infection and case fatality rate in China, Italy, and South Korea.中国、意大利和韩国的 SARS-CoV-2 感染和病死率的年龄分层分析。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12575-12578. doi: 10.26355/eurrev_202012_24054.
3
COVID-19 in Gansu Province, China: Characteristics, measures, and effects.中国甘肃省的新型冠状病毒肺炎：特征、措施及影响
J Glob Health. 2021 Jan 13;11:03001. doi: 10.7189/jogh.11.03001.
4
Letter from China: Managing the second-wave COVID-19 outbreak in Beijing.来自中国的信：应对北京第二波新冠疫情
Respirology. 2021 Mar;26(3):275-276. doi: 10.1111/resp.14002. Epub 2021 Jan 5.
5
Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.中国浙江省 465 例新冠肺炎（COVID-19）住院病例的流行病学、临床和病毒学特征。
Influenza Other Respir Viruses. 2020 Sep;14(5):564-574. doi: 10.1111/irv.12758. Epub 2020 May 19.
6
Age-dependent Gender Differences in COVID-19 in Mainland China: Comparative Study.中国大陆 COVID-19 患者的年龄相关性别差异：比较研究。
Clin Infect Dis. 2020 Dec 3;71(9):2488-2494. doi: 10.1093/cid/ciaa683.
7
SARS-CoV-2 in Italy: Population Density Correlates with Morbidity and Mortality.意大利的 SARS-CoV-2 病毒：人口密度与发病率和死亡率相关。
Jpn J Infect Dis. 2021 Jan 22;74(1):61-64. doi: 10.7883/yoken.JJID.2020.200. Epub 2020 Jun 30.
8
SARS-CoV-2 / COVID-19 in patients on the Swiss national transplant waiting list.瑞士全国移植等待名单上的 SARS-CoV-2/COVID-19 患者。
Swiss Med Wkly. 2020 Dec 31;150:w20451. doi: 10.4414/smw.2020.20451. eCollection 2020 Dec 14.
9
Elevated glucose level leads to rapid COVID-19 progression and high fatality.高血糖水平会导致 COVID-19 迅速恶化并导致高死亡率。
BMC Pulm Med. 2021 Feb 24;21(1):64. doi: 10.1186/s12890-021-01413-w.
10
Policy disparities in fighting COVID-19 among Japan, Italy, Singapore and China.抗击新冠疫情中，日本、意大利、新加坡和中国的政策差异。
Int J Equity Health. 2021 Jan 13;20(1):33. doi: 10.1186/s12939-020-01374-2.

引用本文的文献

1
High-flow nasal cannula oxygen versus conventional oxygen therapy for acute respiratory failure due to COVID-19: a systematic review and meta-analysis.高流量鼻导管吸氧与传统氧疗用于新型冠状病毒肺炎所致急性呼吸衰竭的系统评价和荟萃分析
Ann Intensive Care. 2023 Nov 23;13(1):114. doi: 10.1186/s13613-023-01208-8.
2
Lack of Benefit of High Flow Nasal Oxygen Therapy as Ceiling of Treatment for Severe COVID-19 Pneumonitis in Elderly Frail Patients: A Single Centre Observational Study.高流量鼻导管给氧疗法作为老年体弱患者重症新型冠状病毒肺炎治疗上限缺乏疗效：一项单中心观察性研究
Open Respir Med J. 2022 Jun 22;15:e187430642206271. doi: 10.2174/18743064-v15-e2206271. eCollection 2022.
3
The COVID-19 Driving Force: How It Shaped the Evidence of Non-Invasive Respiratory Support.
新冠疫情的驱动力：它如何塑造了无创呼吸支持的证据
J Clin Med. 2023 May 16;12(10):3486. doi: 10.3390/jcm12103486.
4
Obesity Dysregulates the Immune Response to Influenza Infection and Vaccination Through Metabolic and Inflammatory Mechanisms.肥胖通过代谢和炎症机制扰乱了对流感感染和疫苗接种的免疫反应。
Annu Rev Nutr. 2022 Aug 22;42:67-89. doi: 10.1146/annurev-nutr-062320-115937.
5
Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review.新型冠状病毒肺炎患者严重程度和死亡的预后因素：系统评价。
PLoS One. 2020 Nov 17;15(11):e0241955. doi: 10.1371/journal.pone.0241955. eCollection 2020.
6
Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis.COVID-19 患者接受有创机械通气的病死率：一项荟萃分析。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):54-66. doi: 10.1164/rccm.202006-2405OC.
7
Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review.心力衰竭对 COVID-19 结局的影响：一项荟萃分析和系统评价。
Am J Emerg Med. 2021 Aug;46:204-211. doi: 10.1016/j.ajem.2020.07.009. Epub 2020 Jul 9.
8
Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.肥胖驱动的特异性促解决介质缺陷可能导致 SARS-CoV-2 感染期间的不良后果。
Front Immunol. 2020 Aug 11;11:1997. doi: 10.3389/fimmu.2020.01997. eCollection 2020.
9
Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships.肥胖与 COVID-19 患者：流行病学和生物学关系的全球视角。
Obes Rev. 2020 Nov;21(11):e13128. doi: 10.1111/obr.13128. Epub 2020 Aug 26.
10
Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis.中国 8807 例 COVID-19 患者中合并糖尿病与疾病严重程度或死亡风险的关系：一项荟萃分析。
Diabetes Res Clin Pract. 2020 Aug;166:108346. doi: 10.1016/j.diabres.2020.108346. Epub 2020 Jul 22.